DRUG

Conviction 22HealthcareScan · Thu, Jun 25, 2026

DRUG$63.59-3.97%

ResistanceSupportVol 14

Vol MA14 430.64K

Mar 26Apr 14May 1May 19Jun 8Jun 25

BRIGHT MINDS BIOSCIENCES INC.Biotechnologywww.brightmindsbio.com ↗

Price63.59

Change-3.97%

Gap+0.36%

Rel volume0.36×

Avg volume446.81K

Avg $ vol30.34M

SMA 2068.40

SMA 5078.83

SMA 20073.25

Price vs 50-19.34%

Price vs 200-13.19%

MA stackmixed

50/200 cross—

Supertrenddown · 74.16

RSI (14)39

MACD hist0.43

MACD crossbull · 1d

Stoch %K / %D41 / 43

ADX (14)32

+DI / −DI17 / 24

RSI divergence—

MACD divergence—

ATR %+7.54%

ADR %7.22%

52w high95.99

52w low23.27

From 52w high-33.75%

Above 52w low+173.27%

New 52w highNo

SqueezeOff

Bollinger width53.18%

%B0.37

Donchian pos20.82%

Donchian high90.67

Donchian low56.47

AVWAP (52w high)78.44

vs AVWAP high-18.93%

AVWAP (52w low)71.43

vs AVWAP low-10.97%

OBV trendDown

Chaikin MF (20)-0.30

Today vs 20d0.36×

Avg vol (14d)430.64K

Avg vol (20d)446.81K

Avg $ vol (20d)30.34M

Market cap287.69M

RS 3m (vs SPY)-20.53%

RS 6m (vs SPY)-28.90%

RS line new highNo

Trend template3/8

Technical rank16.9

1 week+6.84%

1 month-26.30%

3 months-14.18%

6 months-23.39%

1 year+127.11%

YTD-23.81%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target164.25

Target upside158.30%

Analyst ratingBuy

Institutional94.34%

Ent. value287.69M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out9.73M

Employees25

ListedMon, Mar 8, 2021

Free float7.2M

Float %74.0%

Short interest805.67K

Days to cover2.9d

Short volume62.4%

Squeeze score52 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.80 vs −$1.17

Last surprise+31.6% beat

Setup gradeD

Conviction22 / 100

Pattern quality—

Tech rank16.9 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance91.04

Support64.45

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in DRUG

All disclosures →

No recent disclosed trades by Congress in DRUG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DRUG

No recent insider (Form 4) filings in DRUG. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in DRUG · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.